President Trump signed an executive order directing the federal government to build a new division inside the National Institutes of Health devoted entirely to women’s health.
Quick Take
- President Trump signed the order at a White House event with First Lady Melania Trump on October 19, 2026.
- The order gives the Department of Health and Human Services 90 days to establish a Women’s Health Division within the National Institutes of Health.
- A new White House Women’s Health Task Force, co-chaired by Robert F. Kennedy Jr. and Chief of Staff Susie Wiles, will coordinate federal efforts.
- The policy covers women’s health from childhood through pregnancy, menopause, and aging, targeting conditions like endometriosis and maternal health.
- The move follows years of research showing women’s health gets a small, shrinking slice of federal science funding.
What The Order Actually Does
The White House titled the action “Advancing Women’s Health to Improve Outcomes in All Phases of Life.” It is an official presidential action, not a proposal or a promise. The document orders the Department of Health and Human Services and the National Institutes of Health to create a dedicated Women’s Health Division within 90 days. That is a hard deadline, not a suggestion, and it puts a clock on an agency that has talked about this problem for decades.
Alongside the new division, the order creates a White House Women’s Health Task Force. Robert F. Kennedy Jr., the Health and Human Services Secretary, and Susie Wiles, the White House Chief of Staff, will co-chair it. Putting the chief of staff in that seat signals this isn’t a side project buried in one agency. It puts women’s health coordination directly inside the West Wing’s chain of command.
A Problem With Decades of Data Behind It
This order did not appear out of nowhere. The National Academies reviewed federal research spending and found women’s health research got just 8.8 percent of National Institutes of Health grant money from 2013 through 2023. That share actually fell, dropping from 9.7 percent to 7.9 percent even as the agency’s overall budget grew. Conditions like endometriosis, fibroids, and polycystic ovary syndrome stayed stuck in the same research gap for years.
Congress tried to fix this once before. The 1993 National Institutes of Health Revitalization Act created the Office of Research on Women’s Health and required federal clinical trials to include women. Thirty years later, researchers still describe major blind spots in how female-specific diseases get studied and funded. That track record is the real backdrop here: a law from 1993 opened the door, but it didn’t close the funding gap.
Scope Stretches Across A Woman’s Entire Life
The order doesn’t target one disease or one age group. White House materials describe coverage spanning infancy, childhood, and adolescence through pregnancy, midlife, menopause, and aging. That breadth matters because women’s health research has historically clustered around reproduction and breast cancer while skipping conditions tied to migraines, autoimmune disease, and menopause-related decline. The Associated Press reported the order specifically names maternal health, mental health, and endometriosis as priority areas.
First Lady Melania Trump has publicly championed the initiative, framing it as a personal priority rather than a routine policy rollout. Her involvement gives the effort a visible face beyond the usual agency press release, which tends to help an initiative survive news cycles instead of fading into bureaucratic paperwork.
Big Goals, Open Questions On Delivery
The order also talks about using advanced computing power, described in White House materials as “super intelligence,” to speed up discoveries about female biology. That’s an ambitious idea, but the released documents don’t spell out which systems, agencies, or safeguards would actually run it. Big tech promises paired with vague mechanics are worth watching closely as this moves from signing ceremony to implementation.
No specific dollar figure or budget line appears in the public materials tied to this order. The real test now is whether the Department of Health and Human Services hits its 90-day deadline to stand up the new division, and whether the task force produces real funding shifts rather than another layer of meetings. Given the documented funding gap stretching back to 1993, conservatives watching this should demand follow-through, not just another announcement.
